{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:01:53Z","timestamp":1792710113325,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCDT"],"published-print":{"date-parts":[[2003,6,1]]},"DOI":"10.2174\/1568009033481949","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T00:49:18Z","timestamp":1111711758000},"page":"163-175","source":"Crossref","is-referenced-by-count":109,"title":["The MYC Oncogene as a Cancer Drug Target"],"prefix":"10.2174","volume":"3","author":[{"given":"Heiko","family":"Hermeking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Cancer Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/63809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T09:10:23Z","timestamp":1448269823000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-0096&volume=3&issue=3&spage=163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568009033481949","relation":{},"ISSN":["1568-0096"],"issn-type":[{"value":"1568-0096","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6,1]]}}}